¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"gray platelet"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® platelet ÇÑ±Û Ç÷¼ÒÆÇ
¼³¸í   
  °ñ¼öÀÇ °Å´ë ¼¼Æ÷ÀΠ°Å´ëÇÙ¼¼Æ÷ÀÇ ¼¼Æ÷Áú ÀϺΰ¡ ¶³¾îÁ®¼­ ¼øÈ¯ Ç÷¾× Áß¿¡ ÃâÇöÇÑ °ÍÀ¸·Î Á÷°æÀÌ 2~4¥ìmÀÇ ÀÛÀº °ú¸³Ã¼ÀÌ´Ù. Ç÷¼ÒÆÇÀº ¼Õ»óÀ» ÀÔÀº Ç÷°üÀÇ ³ëÃâµÈ °áÇÕ Á¶Á÷¿¡ ºÙ¾î ¿©·¯ ¹°ÁúÀ» ºÐºñÇÏ¿© ÁöÇ÷ ¹× Ç÷¾× ÀÀ°í¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • central gray
    Áß½Éȸ»öÁú
  • display gray
    ȸ»öÇ¥½Ã
  • gray
    1. ȸ»ö 2. ±×·¹ÀÌ
  • gray column
    ȸ»öÁú±âµÕ
  • gray commissure
    ȸ»öÁú¸Â±³Â÷
  • gray matter
    ȸ(»ö)Áú
  • gray scale display
    ȸ»öÁ¶Ç¥½Ã
  • gray scale ultrasonography
    ±×·¹À̽ºÄÉÀÏÃÊÀ½ÆÄÃÔ¿µ(¼ú)
  • gray substance
    ȸ»öÁú, ȸ¹éÁú
  • gray syndrome
    ȸ»öÁõÈıº
  • periaqueductal gray substance
    ¼öµµ°üÁÖÀ§È¸»öÁú, ¼ö°üÁÖÀ§È¸»öÁú
  • mean platelet volume
    Æò±ÕÇ÷¼ÒÆÇ¿ëÀû
  • platelet
    Ç÷¼ÒÆÇ
  • platelet activating factor
    Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
  • platelet adhesion
    Ç÷¼ÒÆÇºÎÂø
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gray
    ȸ»ö, ±×·¹ÀÌ
  • gray matter
    ȸ»öÁú
  • platelet adhesion
    Ç÷¼ÒÆÇºÎÂø
  • platelet aggregation
    Ç÷¼ÒÆÇÀÀÁý
  • platelet-specific antigen
    Ç÷¼ÒÆÇƯÀÌÇ׿ø
  • platelet concentrate
    Ç÷¼ÒÆÇ³óÃ๰
  • platelet function disorder
    Ç÷¼ÒÆÇ±â´ÉÀÌ»ó
  • platelet activating factor
    Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
  • platelet-derived growth factor
    Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
  • platelet
    Ç÷¼ÒÆÇ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • central gray
    Áß½Éȸ»öÁú
  • gray column
    ȸ»öÁú±âµÕ
  • gray commissure
    ȸ»öÁú¸Â±³Â÷
  • display gray
    ȸ»öÇ¥½Ã
  • gray scale display
    ȸ»öÁ¶Ç¥½Ã
  • gray
    ȸ»ö, ±×·¹ÀÌ
  • gray matter
    ȸ»öÁú
  • gray softening
    ȸ»ö¿¬È­
  • gray substance
    ȸ»öÁú
  • gray scale ultrasonography
    ȸ»öÁ¶ÃÊÀ½ÆÄÃÔ¿µ¼ú
  • periaqueductal gray substance
    ¼öµµ°üÁÖÀ§È¸»öÁú
  • platelet adhesion
    Ç÷¼ÒÆÇºÎÂø
  • platelet agglutination
    Ç÷¼ÒÆÇÀÀÁý
  • platelet aggregation
    Ç÷¼ÒÆÇÀÀÁý
  • platelet-specific antigen
    Ç÷¼ÒÆÇƯÀÌÇ׿ø
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Gray
    ±×·¹ÀÌ
  • Gray rami communicantes
    ȸ»ö(üéßä)±³ÅëÁö(Îß÷×ò«)
  • Gray unit
    ±×·¹ÀÌ ´ÜÀ§
  • anterior gray commissure
    ¾Õȸ»öÁú¸Â±³Â÷
  • gray cataract
    ȸ»ö¹é³»Àå.
  • gray central
    Áß½Éȸ»öÁú(ñéãýüéßäòõ).
  • gray column
    ȸ¹éÁÖ(üéÛÜñº).
  • gray columns
    ȸ»öÁú±âµÕ
  • gray commissure
    ȸ»öaÂ÷¿¬°á, ȸ¹éa·Ã(üéÛÜÎßææ).
  • gray commissure
    ȸ»öÁú¸Â±³Â÷
  • gray commissure
    ȸ»ö±³Â÷¿¬°á, ȸ¹é±³·Ã(üéÛÜÎßææ).
  • gray hair
    ¹é¸ð
  • gray horn
    ȸ»ö»Ô, ȸ¹é°¢(üéÛÜÊÇ).
  • gray matter
    ȸ»öÁú(üéßäòõ).
  • gray matter
    ȸ»öÁú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anterior gray commissure
    ¾Õȸ»öÁú¸Â±³Â÷
  • central gray (substance)
    Áß½Éȸ»öÁú
  • column of gray matter
    ȸ»öÁú±âµÕ, ȸ¹éÁÖ(üéÛÜñº).
  • column of gray matter
    ȸ»öÁú±âµÕ
  • display, gray
    ȸ»ö Ç¥½Ã (üéßä øúãÆ)
  • gray cataract
    ȸ»ö¹é³»Àå.
  • gray central
    Áß½Éȸ»öÁú(ñéãýüéßäòõ).
  • gray column
    ȸ¹éÁÖ(üéÛÜñº).
  • gray columns
    ȸ»öÁú±âµÕ
  • gray commissure
    ȸ»ö±³Â÷¿¬°á, ȸ¹é±³·Ã(üéÛÜÎßææ).
  • gray commissure
    ȸ»öaÂ÷¿¬°á, ȸ¹éa·Ã(üéÛÜÎßææ).
  • gray commissure
    ȸ»öÁú¸Â±³Â÷
  • gray hair
    ¹é¸ð
  • gray horn
    ȸ»ö»Ô, ȸ¹é°¢(üéÛÜÊÇ).
  • gray matter
    ȸ»öÁú(üéßäòõ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Thrombocyte [Blood platelet]
    Ç÷¼ÒÆÇ
    [¿¾ ¿ë¾î] Ç÷¼ÒÆÇ
  • Thrombocyte [Blood platelet]
    Ç÷¼ÒÆÇ
    [¿¾ ¿ë¾î] Ç÷Àü¼¼Æ÷
  • Posterior gray commissure
    µÚȸ»öÁú¸Â±³Â÷
    [¿¾ ¿ë¾î] ÈÄȸ¹éÁú±³·Ã
  • Anterior gray commissure
    ¾Õȸ»öÁú¸Â±³Â÷
    [¿¾ ¿ë¾î] Àüȸ¹éÁú±³·Ã
  • Central gray (substance)
    Áß½Éȸ»öÁú
    [¿¾ ¿ë¾î] Áß½Éȸ¹éÁú
  • Gray ramus
    ȸ»ö°¡Áö
    [¿¾ ¿ë¾î] ȸ¹éÁö
  • Gray rami communicantes
    ȸ»ö±³Åë°¡Áö
    [¿¾ ¿ë¾î] ȸ¹é±³ÅëÁö
  • Gray matter
    ȸ»öÁú
    [¿¾ ¿ë¾î] ȸ¹éÁú
  • Gray matter (Nuclei and Columns)
    ȸ»öÁú(½Å°æÇÙ°ú ½Å°æ±âµÕ)
    [¿¾ ¿ë¾î] ȸ¹éÁú
  • Column of gray matter
    ȸ»öÁú±âµÕ
    [¿¾ ¿ë¾î] ȸ¹éÁÖ
  • Gray columns
    ȸ»öÁú±âµÕ
    [¿¾ ¿ë¾î] ȸ¹éÁÖ
  • Gray commissure
    ȸ»öÁú¸Â±³Â÷
    [¿¾ ¿ë¾î] ȸ¹é±³·Ã
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anti-gray-hair factor
    Ç×¹é¸ð¹ß ÀÎÀÚ(ù÷ÛÜÙ¾Û¥ì×í­)
  • blood platelet
    Ç÷¼ÒÆÇ(úìá³÷ù)
  • platelet
    Ç÷¼ÒÆÇ(úìá³÷ù)
  • platelet-activating factor
    Ç÷¼ÒÆÇȰ¼º ÀÎÀÚ(úìá³÷ùüÀàõì×í­)
  • platelet cofactor I
    Ç÷¼ÒÆÇ(úìá³÷ù) º¸ÀÎÀÚ (ÜÍì×í­) I
  • platelet cofactor II
    Ç÷¼ÒÆÇ(úìá³÷ù) º¸ÀÎÀÚ(ÜÍì×í­) II
  • platelet-derived growth factor
    Ç÷¼ÒÆÇÀ¯·¡(úìá³÷ùë¦ÕÎ) ¼ºÀåÀÎÀÚ(à÷íþì×í­)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • platelet
    Ç÷¼ÒÆÇ
  • gray
    ȸ»öÀÇ
  • gray matter
    ȸ»öÁú
  • gray matter
    ȸÁú
  • gray scale
    ȸ»öÁ¶, ȸ»ö½ºÄÉÀÏ
  • gray scale display
    ȸ»öÁ¶Ç¥½Ã
  • gray scale ultrasonography
    ȸ»öÁ¶ÃÊÀ½ÆÄ°Ë»ç
  • gray substance
    ȸ»öÁú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PA panic attack; pantothenic acid; paralysis agitans; paranoia; passive aggressive; pathology; patient'...
GPS Goodpasture syndrome; gray platelet syndrome; guinea pig serum; guinea pig spleen
PAF paroxysmal atrial fibrillation; peroxisomal assembly factor; phosphodiesterase-activating factor; pl...
PC avoirdupois weight [Lat. pondus civile]; packed cells; paper chromatography; paracortex; parent cell...
PFKP phosphofructokinase, platelet type; 6-phosphofructo-2-kinase, platelet type
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
GPS Gray platelet syndrome
Gy 2-gray
CG Central gray
CGE Cobalt Gray Equivalent
GM Gray matter
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • disorder of blood platelet
    Ç÷¼ÒÆÇ Àå¾Ö
  • platelet
    Ç÷¼ÒÆÇ
    1. °ñ¼ö¿¡ ÀÖ´Â °ÅÇÙ ¼¼Æ÷ÀÇ ÆÄÆíÀ¸·Î Á÷°æÀÌ 2-4 §­ Á¤µµ·Î ÇÙÀÌ ¾ø´Ù. Ç÷°ü ¼Õ»ó ½Ã Ç÷°ü ¼Õ»ó ºÎÀ§¸¦ ±â°èÀûÀ¸·Î Æä¼âÇϸç, Ç÷¼ÒÆÇ¿¡¼­ À¯¸®µÈ ¹°ÁúÀÌ Ç÷°üÀ» °­ÇÏ°Ô ¼öÃà½ÃÅ´À¸·Î½á ÁöÇ÷ÀÛ¿ëÀ» ÇÑ´Ù. ¶ÇÇÑ Ç÷¾× ÀÀ°í¿¡µµ °ü¿©ÇÑ´Ù. 2. ÀÛÀº ¿øÇüÁú ÆÇ ¸ð¾çÀ̰í, ÇÙÀÌ ¾ø±â ¶§¹®¿¡ ÁøÁ¤ÇÑ ÀǹÌÀÇ ¼¼Æ÷°¡ ¾Æ´Ï´Ù. À̵éÀº °ñ¼ö¿¡ ÀÖ´Â °Å´ë ÇÙ ¼¼Æ÷ÀÇ ¼¼Æ÷Áú Á¶°¢µéÀÌ ¶³¾îÁ®¼­ µÈ °ÍÀ¸·Î ¼øÈ¯ Ç÷¾× ³»¿¡´Â »ö±òÀÌ ¾ø´Ù.
  • platelet aggragating factor
    Ç÷¼ÒÆÇ ÀÀÁý ¿ä¼Ò, Ç÷¼ÒÆÇ ¾ÇÈ­ ÀÎÀÚ, Ç÷¼ÒÆÇ ¾ÇÈ­ ¿äÀÎ
    ¸é¿ª ±Û·ÎºÎ¸° E¿¡ °¨±¤µÈ È£¿°±â±¸¿¡¼­ÀÇ Ç׿ø ¹ÝÀÀ¿¡ ÀÇÇØ Ç÷¾× ³»¿¡ »ý¼ºµÈ ¹°Áú·Î¼­ Ç÷¼ÒÆÇÀ» ÀÀÁý½Ã۸ç, ¿°ÁõÀ» À¯¹ß½ÃŲ´Ù.
  • platelet concentrate
    Ç÷¼ÒÆÇ ³óÃà¾×
  • platelet fector III
    Ç÷¼ÒÆÇ Á¦ »ï ÀÎÀÚ
  • platelet transfusion
    Ç÷¼ÒÆÇ ¼öÇ÷
  • platelet-activating factor
    Ç÷¼ÒÆÇ Ȱ¼º ÀÎÀÚ
  • qualitative platelet defect
    Á¤»ó Ç÷¼ÒÆÇ °áÇÌÁõ, ÁúÀû Ç÷¼ÒÆÇ °áÇÔ
  • column of gray matter
    ȸ»öÁú ±âµÕ, ȸ¹éÁÖ
  • lead gray
    ³³ ȸ»ö
  • midbrain periaqueductal gray matter
    Áß³ú ¼öµµ ÁÖÀ§ ȸ»öÁú, Áß³ú ¼öµµ ÁÖÀ§ ȸ¹éÁú
  • periaqueductal gray matter
    ¼ö°ü ÁÖº¯ ȸ»öÁú, ¼ö°ü ÁÖº¯ ȸ¹éÁú
  • reddish gray
    Àûȸ»ö
  • slate gray color
    ÀÚȸ»ö
    £Àº Ǫ¸¥»öÀ» ¶í ȸ»ö.
  • slate-gray area
    ÀÚȸ»ö ºÎÀ§
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
gray level also gray value <microscopy> The brightness of pixels in a digitised video image, commonly expressed in integers ranging from 0 (black) to 255 (white) for an 8-bit digital signal.
(05 Aug 1998)
acquired platelet function defect <haematology> Platelet function can be affected by a number of different disease processes including polycythaemia vera, leukaemia, myelofibrosis, renal failure, multiple myeloma and some medications (for example penicillins, salicylates, phenothiazines).
Disturbed blood clotting can be manifested by: easy bruising, bleeding gums, nosebleeds, abnormal vaginal bleeding, rectal bleeding, skin rash, vomiting blood, coughing up blood or blood in the urine. A measure of bleeding time and coagulation profile will be part of the evaluation.
(29 Dec 1997)
anterior gray column The central gray matter of the spinal cord surrounding the central canal.
Synonym: substantia intermedia centralis et lateralis, anterior gray column, Stilling's gelatinous substance, substantia gelatinosa centralis.
(05 Mar 2000)
antigens, human platelet Human alloantigens expressed only on platelets, specifically on platelet membrane glycoproteins. These platelet-specific antigens are immunogenic and can result in pathological reactions to transfusion therapy.
(12 Dec 1998)
anti-platelet agents Medications that, like aspirin, reduce the tendency of platelets in the blood to clump and clot.
(12 Dec 1998)
receptors, platelet-derived growth factor Specific molecular sites or structures on cell membranes that react with platelet-derived growth factor, its analogs, or antagonists, to elicit or to inhibit the specific response of the cell to this factor. Pdgf binds with different affinities and specificities to two structurally related receptors, the alpha-receptor and the beta-receptor. Both of these receptors are transmembrane proteins with an intracellular, ligand-stimulatable protein kinase domain.
(12 Dec 1998)
matter, gray The cortex of the brain which contains nerve cell bodies. The gray matter is as opposed to the white matter, the part of the brain that contains myelinated nerve fibres. The gray matter is so named because it in fact appears gray. In the mysterious affair at styles (1920), agatha christie first quoted the fictional belgian detective hercule poirot in regard to his gray matter: 'this affair must be unravelled from within.' he tapped his forehead. 'these little grey cells. It is up to them as you say over here.'
(12 Dec 1998)
medication, anti-platelet Platelet-blocking drugs. Drugs that, like aspirin, reduce the tendency of platelets in the blood to clump and clot.
(12 Dec 1998)
central gray substance In general: the predominantly small-celled gray matter adjoining or surrounding the central canal of the spinal cord and the third and fourth ventricles of the brainstem, in particular: the thick sleeve of gray matter surrounding the cerebral sylvian aqueduct in the midbrain, rostrally continuous with the posterior nucleus of the hypothalamus; in sections stained for myelin it stands out from the adjoining tectum and tegmentum by the poverty of its myelinated fibres.
Synonym: substantia grisea centralis.
(05 Mar 2000)
periaqueductal gray Central gray matter surrounding the cerebral aqueduct in the mesencephalon. Physiologically it is probably involved in rage reactions, the lordosis reflex, feeding responses, bladder tonus, and pain.
(12 Dec 1998)
Gray <radiobiology, unit> The new international system unit (SI unit) of absorbed dose of radiation (Gy), 1 Gy = 1 J kg-1 = 100 rad.
(16 Dec 1997)
gray cataract A cataract of gray colour, usually seen in senile, mature, or cortical cataract.
(05 Mar 2000)
gray collie syndrome An autosomal recessive, inherited immunodeficiency of gray collie dogs characterised by overwhelming recurrent bacterial infections, bleeding, and coat colour dilution.
Synonym: gray collie syndrome.
(05 Mar 2000)
gray columns The three somewhat ridge-shaped masses of gray matter (anterior, posterior, and lateral columns) that extend longitudinally through the centre of each lateral half of the spinal cord; in transverse sections these columns appear as gray horns and are therefore commonly called ventral or anterior, dorsal or posterior, and lateral horn, respectively.
Synonym: columnae griseae.
(05 Mar 2000)
gray degeneration Degeneration of the white substance of the spinal cord, the fibres of which lose their myelin sheaths and become darker in colour.
(05 Mar 2000)
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
gray platelet s. a rare deficiency of the alpha granules of platelets, resulting in a bleeding disorder that may include ecchymoses, petechiae, and epistaxis from infancy on.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gray-haired
    ¹é¹ßÀÇ
  • gray-headed
    ¹é¹ßÀÇ
  • French gray
    ÃÊ·Ï»öÀ» ¶í ȸ»ö
  • Gray
    ±×·¹ÀÌ(¿µ±¹ÀÇ ½ÃÀÎ)
  • Gray Friar
    ÇÁ¶õü½ºÄÚȸ ¼öµµ»ç
  • Gray Line
    ¹Ì±¹ÀÇ ´ë±Ô¸ð °ü±¤¹ö½º ȸ»ç
  • Gray Panther
    ±×·¹ÀÌÆÒ¼­(³ëÀÎÀÇ ±Ç¸® È®´ë¸¦ ²ÒÇÏ´Â ¿îµ¿ ´ÜüÀÇ ÀÏ¿ø) ,
  • Gray Thomas
    (1716-1771)¿µ±¹ÀÇ ½ÃÀÎ
  • Gray's Inn
    ±×·¹ÀÌÁîÀÎ ¹ýÇпø
  • charcoal gray
    ÁøÈ¸»ö
  • field gray
    ¾Ïȸ»ö;±ºº¹;µ¶ÀϺ´
  • gray
    ȸ»ö(ÀÇ);¹Ú¸í;Ȳȥ;(¾ó±¼ÀÌ)â¹éÇÑ;¹é¹ßÀÇ;À½Ä§ÇÑ;´ÄÀº;¿ø¼÷ÇÑ
  • gray area
    (¾ç±Ø »çÀÌÀÇ)Áß°£ ¿µ¿ª;À̵µÀúµµ ¾Æ´Ñ(¾Ö¸ÅÇÑ)ºÎºÐ(»óȲ);=GREY AREA
  • gray cells
    ³ú;³ú¼ö;µÎ³ú;Áö´É;Áö¼º
  • gray crow
    =GRAYBACK
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á